CA1242392A - Produits et methodes pour le traitement du cancer - Google Patents

Produits et methodes pour le traitement du cancer

Info

Publication number
CA1242392A
CA1242392A CA000464885A CA464885A CA1242392A CA 1242392 A CA1242392 A CA 1242392A CA 000464885 A CA000464885 A CA 000464885A CA 464885 A CA464885 A CA 464885A CA 1242392 A CA1242392 A CA 1242392A
Authority
CA
Canada
Prior art keywords
protein
igg
tumor
serum
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000464885A
Other languages
English (en)
Inventor
David S. Terman
Joseph P. Balint
John J. Langone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/542,239 external-priority patent/US4699783A/en
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of CA1242392A publication Critical patent/CA1242392A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA000464885A 1983-10-14 1984-10-05 Produits et methodes pour le traitement du cancer Expired CA1242392A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US542,239 1983-10-14
US06/542,239 US4699783A (en) 1983-03-11 1983-10-14 Products and methods for treatment of cancer

Publications (1)

Publication Number Publication Date
CA1242392A true CA1242392A (fr) 1988-09-27

Family

ID=24162926

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000464885A Expired CA1242392A (fr) 1983-10-14 1984-10-05 Produits et methodes pour le traitement du cancer

Country Status (1)

Country Link
CA (1) CA1242392A (fr)

Similar Documents

Publication Publication Date Title
US4699783A (en) Products and methods for treatment of cancer
US5879679A (en) Antigen-based heteropolymers and method for treating autoimmune diseases using the same
Henson et al. IMMUNOLOGICAL INDUCTION OF INCREASED VASCULAR PERMEABILITY: I. A Rabbit Passive Cutaneous Anaphylactic Reaction Requiring Complement, Platelets, and Neutrophils
Mannik et al. Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits.
EP0091784B1 (fr) Produits pour le traitement du cancer
Brown et al. The localization of immunoglobulin and immune complexes in lymphoid tissue
JPH0713026B2 (ja) 血友病a抑制患者の治療のための製剤及び該製剤の製造方法
Cunnington et al. Oxygen-binding and immunological properties of complexes between dextran and animal haemoglobins
Natori et al. Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, Meth-A
US4167557A (en) Ubiquitous immunopoietic polypeptide (UBIP) and methods
CA1135185A (fr) Agent therapeutique pour des maladies a immunite complexe
JPS6053009B2 (ja) 肝炎ウイルスbによる急性または慢性の感染治療用の新規医薬
CA1242392A (fr) Produits et methodes pour le traitement du cancer
Yamamoto et al. The natural mediator for PMN emigration in inflammation: V. The site of structural change in the chemotactic generation of immunoglobulin G by inflammatory SH-dependent protease
US5114710A (en) M-csf as a therapeutic agent for thrombocytopenia
Marusić-Galesić et al. Cellular immune response to the antigen administered as an immune complex in vivo
Nakamura et al. Oligomeric IgA: the major component of the in vitro primary response of mouse spleen fragments
CA1233748A (fr) Produits et methodes pour le traitement du cancer
Stevenson et al. Preparation and properties of FabIgG, a chimeric univalent antibody designed to attack tumour cells
Takahashi et al. Preparation of fluorescent antibody reagents monospecific to heavy chains of human immunoglobulin
JPS58201717A (ja) 腫瘍免疫製剤およびその製造方法
Jager et al. Immunological studies of three antitoxin containing globulin fractions of the horse
Ochiya et al. Induction of macrophage disappearance reaction by immunoadsorbed MIF
Griswold et al. Glomerular localization of antigen and antibody in rabbits following intravenous administration of serum cryoproteins from homologous animals with acute serum sickness
JPH0794475B2 (ja) 純粋なエリスロポエチンの製造法

Legal Events

Date Code Title Description
MKEX Expiry